Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Tirzepatide, the only FDA-approved dual GIP/GLP-1 receptor agonist, is a peptide with potent and imbalanced co-agonism at both GIPR and GLP-1R
Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Victoza, Saxenda, Byetta, Bydureon, Adlyxin, Tanzeum, Eperzan, Orfoglip, and Retara are registered trademarks of their respective owners
Taking two doses too close together can spike the level of medication in your system, dramatically increasing the risk of side effects
Hormone replacement therapy and GLP-1 receptor agonists target completely different systems in the body
US$ 26.40
US$ 28.85
US$ 25.75
US$ 21.34
US$ 21.12
US$ 28.80
US$ 24.11
US$ 22.26
